AIM ImmunoTech Inc.

Healthcare · Biotechnology · United States

Last price 0.164 USD (Oct 30, 2026, 9:30 AM EDT) · Market cap 4.99M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company’s flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts. It is also ...